Epioxa, the first FDA-approved epithelium-on cross-linking procedure, is now commercially available, according to a press release from Glaukos.

Waist circumference, not BMI, was tied to increased risk for adiposity-related heart failure, and the association was ...

The FDA has approved the first medication for cholestatic pruritus in adult patients with primary biliary cholangitis.The approval of linerixibat (Lynavoy, GSK) — an ileal bile acid transporter ...

Roflumilast cream 0.05% was well-tolerated and effective for the long-term treatment of mild to moderate atopic dermatitis in ...

With the singular exception of punctal or canalicular occlusion, when we are talking about in-office dry eye disease ...

Adults with diabetes had an elevated risk for dementia, with a higher risk among those with type 1 compared with type 2 ...

Finerenone demonstrated safety and reduced albuminuria for patients with chronic kidney disease, type 2 diabetes and a ...

Ndemex, a formulation of tea tree oil designed to promote ocular hygiene, is now available.It can be used once daily to help “support good ocular health in the fight against blepharitis and other ...

Please provide your email address to receive an email when new articles are posted on . Patients taking GLP-1s had a higher propensity to develop osteoporosis vs. matched controls. Patients taking GLP ...

The likelihood that a person with early-stage non-small cell lung cancer will receive curative treatment still varies considerably by race, even though 3 decades have passed since researchers first ...

The FDA approved a higher 7.2 mg dose of injectable semaglutide for adults with overweight and obesity, Novo Nordisk announced. Once-weekly injectable semaglutide 7.2 mg (Wegovy HD, Novo Nordisk) ...

A GIP/GLP-1/glucagon triple agonist reduced HbA1c by up to 1.9 percentage points at 40 weeks for adults with type 2 diabetes, according to topline results from the TRANSCEND-T2D-1 trial. Retatrutide ...